MDT - Medtronic Is A Healthy Portfolio Boost
2024-02-18 03:22:05 ET
Summary
- Medtronic's revenue soars 88%, leading healthcare innovation, while Non-GAAP EPS up 40%, showcasing steady growth.
- Medtronic has decent growth opportunities and limited risks.
- With Medtronic's P/E ratio below average, I believe it's a buy.
Introduction
Medical devices remain a very stable business within the healthcare sector, even in times of economic uncertainty. Medical devices can be a suitable investment with fluctuating markets and economic cycles due to macro data that postpone the anticipated interest rate decrease. This segment is stable due to the constant demand for market medical procedures, thus making it more stable. I believe companies within this b sector that lead innovation are particularly compelling, as there is less competition than generic manufacturers....
Medtronic Is A Healthy Portfolio Boost